Kwality Pharmaceuticals Limited (BOM:539997)

Market Cap	7.79B
Revenue (ttm)	3.46B
Net Income (ttm)	298.03M
Shares Out	10.38M
EPS (ttm)	28.91
PE Ratio	25.98
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,698
Average Volume	17,021
Open	790.10
Previous Close	797.10
Day's Range	749.90 - 811.80
52-Week Range	481.00 - 1,069.95
Beta	-0.11
RSI	44.84
Earnings Date	May 30, 2025

About Kwality Pharmaceuticals

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally. It offers its products in various dosage forms, including liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments/cream, external preparations, ORS, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized and covid products, syrups, daunorubicin, and other various categories, such ...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 806
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539997

Financial Performance

In 2023, Kwality Pharmaceuticals's revenue was 3.07 billion, an increase of 22.36% compared to the previous year's 2.51 billion. Earnings were 237.96 million, an increase of 22.84%.